PE20030429A1 - Esteres de analogos de 3-desoxi-vitamina d3 - Google Patents
Esteres de analogos de 3-desoxi-vitamina d3Info
- Publication number
- PE20030429A1 PE20030429A1 PE2002000921A PE2002000921A PE20030429A1 PE 20030429 A1 PE20030429 A1 PE 20030429A1 PE 2002000921 A PE2002000921 A PE 2002000921A PE 2002000921 A PE2002000921 A PE 2002000921A PE 20030429 A1 PE20030429 A1 PE 20030429A1
- Authority
- PE
- Peru
- Prior art keywords
- deoxy
- vitamin
- esters
- inden
- octahydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32387001P | 2001-09-21 | 2001-09-21 | |
| US32395701P | 2001-09-21 | 2001-09-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20030429A1 true PE20030429A1 (es) | 2003-05-15 |
Family
ID=26984180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2002000921A PE20030429A1 (es) | 2001-09-21 | 2002-09-19 | Esteres de analogos de 3-desoxi-vitamina d3 |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1430026A1 (ko) |
| JP (1) | JP2005503434A (ko) |
| KR (1) | KR100628586B1 (ko) |
| CN (1) | CN1285573C (ko) |
| AU (1) | AU2002338672B2 (ko) |
| BR (1) | BR0212719A (ko) |
| CA (1) | CA2459789A1 (ko) |
| MX (1) | MXPA04002640A (ko) |
| PA (1) | PA8554901A1 (ko) |
| PE (1) | PE20030429A1 (ko) |
| PL (1) | PL370352A1 (ko) |
| RU (1) | RU2296121C2 (ko) |
| UY (1) | UY27448A1 (ko) |
| WO (1) | WO2003027065A1 (ko) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL376148A1 (en) * | 2002-10-23 | 2005-12-27 | Leo Pharma A/S | Vitamin d analogues, compositions comprising said analogues and their use |
| AU2005289664A1 (en) * | 2004-09-24 | 2006-04-06 | Bioxell S.P.A. | 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin D3 compounds and methods of use thereof |
| WO2006051106A1 (en) | 2004-11-12 | 2006-05-18 | Bioxell Spa | Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer |
| CN102124301B (zh) | 2008-08-22 | 2014-04-02 | Nxp股份有限公司 | 基于位置的服务 |
| CN110339205B (zh) * | 2019-08-19 | 2021-08-24 | 山东德信生物科技有限公司 | 富氢水组合物在抑制六价铬诱导的df-1细胞内质网应激及自噬中的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG70010A1 (en) * | 1996-05-23 | 2000-01-25 | Hoffmann La Roche | Fluorinated vitamin d3 analogs |
| DE69814109T2 (de) * | 1997-09-08 | 2004-02-26 | F. Hoffmann-La Roche Ag | 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga |
| US6331642B1 (en) * | 1999-07-12 | 2001-12-18 | Hoffmann-La Roche Inc. | Vitamin D3 analogs |
-
2002
- 2002-09-12 WO PCT/EP2002/010233 patent/WO2003027065A1/en not_active Application Discontinuation
- 2002-09-12 EP EP02777075A patent/EP1430026A1/en not_active Withdrawn
- 2002-09-12 JP JP2003530656A patent/JP2005503434A/ja active Pending
- 2002-09-12 BR BR0212719-9A patent/BR0212719A/pt not_active IP Right Cessation
- 2002-09-12 CA CA002459789A patent/CA2459789A1/en not_active Abandoned
- 2002-09-12 RU RU2004112217/04A patent/RU2296121C2/ru not_active IP Right Cessation
- 2002-09-12 MX MXPA04002640A patent/MXPA04002640A/es active IP Right Grant
- 2002-09-12 KR KR1020047004110A patent/KR100628586B1/ko not_active IP Right Cessation
- 2002-09-12 PL PL02370352A patent/PL370352A1/xx not_active Application Discontinuation
- 2002-09-12 CN CNB028185285A patent/CN1285573C/zh not_active Expired - Fee Related
- 2002-09-12 AU AU2002338672A patent/AU2002338672B2/en not_active Ceased
- 2002-09-18 PA PA20028554901A patent/PA8554901A1/es unknown
- 2002-09-19 PE PE2002000921A patent/PE20030429A1/es not_active Application Discontinuation
- 2002-09-20 UY UY27448A patent/UY27448A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PA8554901A1 (es) | 2003-12-10 |
| JP2005503434A (ja) | 2005-02-03 |
| BR0212719A (pt) | 2004-08-03 |
| RU2296121C2 (ru) | 2007-03-27 |
| CA2459789A1 (en) | 2003-04-03 |
| AU2002338672B2 (en) | 2006-03-09 |
| PL370352A1 (en) | 2005-05-16 |
| MXPA04002640A (es) | 2004-06-07 |
| CN1556795A (zh) | 2004-12-22 |
| UY27448A1 (es) | 2003-03-31 |
| WO2003027065A1 (en) | 2003-04-03 |
| CN1285573C (zh) | 2006-11-22 |
| RU2004112217A (ru) | 2005-07-10 |
| EP1430026A1 (en) | 2004-06-23 |
| KR100628586B1 (ko) | 2006-09-26 |
| KR20040035853A (ko) | 2004-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20011104A1 (es) | Un proceso para la preparacion de analogos de epotilona | |
| PE20020593A1 (es) | Activadores de glucocinasa del tipo isoindolin-2-ona | |
| RU94044671A (ru) | Применение непептидных антагонистов рецептора тахикинина | |
| ATE331713T1 (de) | Verfahren zur herstellung von 5-nitrobenzofuranen | |
| CY1111396T1 (el) | Ρινικη χορηγηση μετοκλοπραμιδης για την αγωγη της γαστροπαρεσης | |
| PE20010402A1 (es) | Derivados de 1,5-dihidropirrol-2-ona sustituida | |
| SE8704248D0 (sv) | Medical use | |
| PE20030429A1 (es) | Esteres de analogos de 3-desoxi-vitamina d3 | |
| IL162614A (en) | Alpha tocopherol esters for use in treating culture-borne cell disease by aerosol administration | |
| ES2064661T3 (es) | 11-ceto o hidroxi-3,5-dieno-esteroides como inhibidores de esteroide-5-alfa-reductasa. | |
| RU2019119778A (ru) | Применение цементов на основе оксидов металлов | |
| ES2202156T3 (es) | Nuevos analogos de 2-descarboxi-2-fosfinico prostaglandina f. | |
| CO5160251A1 (es) | Analogos de prostaglandinas selectivos del receptor fp c16 insaturados | |
| ES539123A0 (es) | Un compuesto de 3-indolcarboxamida | |
| WO2001014360A3 (en) | Benzopyrans and benzothiopyrans as rar selective retinoid agonists | |
| NO20030919D0 (no) | Trombomodulinanaloger til anvendelse ved rekonvalesens etter ryggmargsskade | |
| IS8306A (is) | Augnsamsetningar til að meðhöndla aungháþrýsting | |
| US5149536A (en) | Dental root canal bacterialcidal lubricant | |
| CA1305420C (en) | Pharmaceutical preparation having antihypertensive activity | |
| DE60121459D1 (de) | Cyanidinmischung zur behandlung von dickdarmkrebs | |
| TW200505882A (en) | Benzothiazole derivatives | |
| AR040202A1 (es) | Combinacion de un agente inhibidor de la secrecion de acido y un inhibidor de reflujo para el tratamiento de la gerd | |
| KR910007887A (ko) | W-페녹시-헤테로사이클릭 화합물 | |
| ATE289817T1 (de) | Arzneimittelzusammenstellung zur behandlung des erhöhten augeninnendrucks oder des glaukom | |
| PE118899A1 (es) | Metodo para aumentar el volumen oseo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |